In an article1
titled “Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure” by
Shaoxuan Hu, Yuqin Song, Xiuhua Sun, Liping Su, Wei Zhang, Jing Jia, Ou Bai, Sheng Yang, Rong Liang, Xiaoling Li, Huilai Zhang, Yuhuan Gao,
Weijing Zhang, Xiubin Xiao, Huizheng Bao, Ningju Wang, Hanyun Ren, Xinan Cen, Shun'e Yang, Yu Zhao, Yinan Wang, Yalan Wang, Aichun
Liu, Jingwen Wang, Yuankai Shi, Ming Yuan, Yufu Li, Xiaohui He, the affiliation in correspondence section and affiliation of Shaoxuan Hu should be corrected:
第一作者机构:[1]Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China[2]Peking Union Med Coll, Beijing, Peoples R China[7]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China[2]Peking Union Med Coll, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Hu Shaoxuan,Song Yuqin,Sun Xiuhua,et al.Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018)[J].CANCER SCIENCE.2019,110(4):1503-1503.doi:10.1111/cas.13927.
APA:
Hu, Shaoxuan,Song, Yuqin,Sun, Xiuhua,Su, Liping,Zhang, Wei...&He, Xiaohui.(2019).Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018).CANCER SCIENCE,110,(4)
MLA:
Hu, Shaoxuan,et al."Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018)".CANCER SCIENCE 110..4(2019):1503-1503